Amarin Corporation plc (AMRN)
NCM · Drug Manufacturers - General
Sources: Yahoo Finance (quote, statistics) · SEC EDGAR (filings, insider trades, 13F holders) · company filings & press wires
Company overview
Amarin Corporation plc, a pharmaceutical company, engages in the commercialization and development of therapeutics for the treatment of cardiovascular diseases in the United States, Europe, and internationally. It offers VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for reducing triglyceride levels in adult patients with severe hypertriglyceridemia. The company sells its products principally through wholesalers, selected regional wholesalers, and retail and mail order pharmacy providers. It has a collaboration with Mochida Pharmaceutical Co., Ltd. to develop and commercialize drug products and indications based on the active pharmaceutical ingredient in Vascepa, the omega-3 acid, EPA. The company was formerly known as Ethical Holdings plc and changed its name to Amarin Corporation plc in 1999. Amarin Corporation plc was incorporated in 1989 and is headquartered in Dublin, Ireland.
Peers in Drug Manufacturers - General
All in industry →Eli Lilly and Company
Johnson & Johnson
AbbVie Inc.
AstraZeneca PLC
Merck & Co., Inc.
Novartis AG
Amgen Inc.
Gilead Sciences, Inc.
Novo Nordisk A/S
Pfizer Inc.
Recent press releases
April 2026
AMARIN CORP PLC\UK — DEF 14A Filing
# 🧾 What This Document Is This is a **Definitive Proxy Statement (DEF 14A)**. Think of it as an invitation and information packet for Amarin's shareholders. It's sent ahead of the **Annual General Meeting (AGM)** scheduled for **May 13, 2026**, to explain what will be voted on and provide key comp
March 2026
AMARIN CORP PLC\UK — PRE 14A Filing
# 🧾 What This Document Is This is a **PRELIMINARY proxy statement** (form PRE 14A) for **Amarin Corporation plc**. It's a formal notice and information packet sent to shareholders ahead of the company's **2026 Annual General Meeting**. Think of it as the agenda and instruction manual for a company'
SEC filings
All filings →Insider trades
All insider trades →Amarin Corporation plc has no reported insider trades in the last 90 days.